Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bioasis Technologies Inc (OP: BIOAF ) 0.0001 UNCHANGED Last Price Updated: 9:30 AM EDT, Aug 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Bioasis Technologies Inc Bioasis Provides Corporate Update and Announces Suspension of Operations June 20, 2023 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Provides Update on Business Operations March 23, 2023 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Announces AGM Results and Provides Update on Financial Position February 03, 2023 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc January 23, 2023 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending November 30, 2022 January 19, 2023 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Technologies Inc. Mails Management Information Circular for Annual and Special Meeting of Securityholders January 11, 2023 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Technologies Inc. Announces Amendments to Arrangement Agreement with Midatech Pharma plc December 19, 2022 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Technologies Inc. Announces Shareholder Webinar December 14, 2022 From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Technologies Inc. Announces Merger with Midatech Pharma plc December 13, 2022 US$10M Registered Direct Offering and PIPE to Strengthen Balance Sheet of Combined Company From Bioasis Technologies Inc. Via GlobeNewswire Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2022 October 28, 2022 From Bioasis Technologies Inc. Via GlobeNewswire The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine May 11, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Bioasis Technologies’ xB3 Platform Unlocks Revolutionary Neurological Disease Treatments February 18, 2022 Via Get News Bioasis Technologies Breaks through Blood-Brain Barrier with xB3 platform, Revolutionizing Neurological Disease Treatment October 22, 2021 Via Get News Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.